Application 210361
- Type
- NDA
- Sponsor
- DERMIRA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | QBREXZA | GLYCOPYRRONIUM TOSYLATE | CLOTH;TOPICAL | EQ 2.4% BASE | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 69489-411 | Qbrexza | glycopyrronium | Journey Medical Corporation | NDA | Current |
| 69489-411 | Qbrexza | glycopyrronium | Journey Medical Corporation | NDA | Current |
| 69489-411 | Qbrexza | glycopyrronium | Journey Medical Corporation | NDA | Current |
| 70428-011 | Qbrexza | glycopyrronium | Dermira, Inc. | NDA | Current |
| 70428-011 | Qbrexza | glycopyrronium | Dermira, Inc. | NDA | Current |
| 70428-011 | Qbrexza | glycopyrronium | Journey Medical Corporation | NDA | Current |